REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Patent Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PHARMA PATENT Kereskedelmi Tanacsado es Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pharma Patent Kft. is a company based in Hungary, with its head office in Budapest. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Pharma Patent Kft. was incorporated on September 23, 1998. Pharma Patent Kft. currently employs 19 (2024) people. From the latest financial highlights, Pharma Patent Kft. reported a net sales revenue increase of 29% in 2023. Its’ total assets recorded a growth of 21.82%. Pharma Patent Kft.’s net profit margin increased by 7.68% in 2023.

Headquarters
Vaci ut 36-38. 4. emelet
Budapest; Budapest; Postal Code: 1132

Contact Details: Purchase the Pharma Patent Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Patent Kft. report to view the information.
Outstanding Shares:
Purchase the Pharma Patent Kft. report to view the information.
Registered Capital:
Purchase the Pharma Patent Kft. report to view the information.
Financial Auditors:
Purchase the Pharma Patent Kft. report to view the information.
Incorporation Date:
September 23, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Pernix Pharma Kft.
Company Performance
Financial values in the chart are available after Pharma Patent Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
29%
Total operating revenue
28.82%
Operating profit (EBIT)
4.23%
EBITDA
8.09%
Net Profit (Loss) for the Period
119.77%
Total assets
21.82%
Total equity
24.8%
Operating Profit Margin (ROS)
-5.06%
Net Profit Margin
7.68%
Return on Equity (ROE)
11.02%
Debt to Equity Ratio
-12.22%
Quick Ratio
-0.05%
Cash Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?